Jeryl L Hilleman insider trades: NovoCure (NVCR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeryl reports to the SEC
and 6 more companies
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | NVCR | ↓ Sell | 2,945 | $15.77 | $46K | Direct | Jun 3, 2026 (1d) |
| Jun 3, 2025 | NVCR | ↓ Sell | 999 | $17.26 | $17K | Direct | Jun 4, 2025 (1d) |
| Jun 20, 2023 | SIBN | ↓ Sell | 4,162 | $28.37 | $118K | Direct | Jun 20, 2023 (0d) |
| Jun 13, 2022 | SIBN | ↓ Sell | 1,924 | $13.81 | $27K | Direct | Jun 14, 2022 (1d) |
| Jun 10, 2022 | NVCR | ↓ Sell10b5-1 | 407 | $69.61 | $28K | Direct | Jun 16, 2022 (6d) |
| Jun 25, 2021 | SIBN | ↓ Sell | 4,400 | $33.71 | $148K | Direct | Jun 28, 2021 (3d) |
| Dec 18, 2020 | NVCR | ↓ Sell10b5-1 | 2,500 | $166.40 | $416K | Direct | Dec 22, 2020 (4d) |
| Jun 26, 2019 | NERV | ↑ Buy | 1,000 | $5.25 | $5K | Direct | Jun 27, 2019 (1d) |
| Apr 2, 2019 | XENT | ↓ Sell | 51,200 | $32.18 | $1.6M | Direct | Apr 3, 2019 (1d) |
| Oct 8, 2018 | XENT | ↓ Sell | 12,833 | $27.99 | $359K | Direct | Oct 10, 2018 (2d) |
| Sep 14, 2018 | XENT | ↓ Sell | 12,833 | $28.92 | $371K | Direct | Sep 18, 2018 (4d) |
| Jun 5, 2018 | XENT | ↓ Sell | 12,833 | $41.70 | $535K | Direct | Jun 7, 2018 (2d) |
| May 3, 2018 | XENT | ↓ Sell | 12,833 | $39.94 | $513K | Direct | May 7, 2018 (4d) |
| Apr 3, 2018 | XENT | ↓ Sell | 12,833 | $37.66 | $483K | Direct | Apr 4, 2018 (1d) |
| Mar 6, 2018 | XENT | ↓ Sell | 12,833 | $35.92 | $461K | Direct | Mar 7, 2018 (1d) |
| Feb 6, 2018 | XENT | ↓ Sell | 12,833 | $35.80 | $459K | Direct | Feb 7, 2018 (1d) |
| Jan 11, 2018 | XENT | ↓ Sell | 12,835 | $33.81 | $434K | Direct | Jan 12, 2018 (1d) |
| Dec 4, 2017 | XENT | ↓ Sell | 12,833 | $30.06 | $386K | Direct | Dec 5, 2017 (1d) |
| Nov 6, 2017 | XENT | ↓ Sell | 12,833 | $27.78 | $357K | Direct | Nov 6, 2017 (0d) |
| Oct 4, 2017 | XENT | ↓ Sell | 12,833 | $29.96 | $384K | Direct | Oct 5, 2017 (1d) |
| Sep 5, 2017 | XENT | ↓ Sell | 12,833 | $31.05 | $398K | Direct | Sep 6, 2017 (1d) |
| Aug 4, 2017 | XENT | ↓ Sell | 12,833 | $29.00 | $372K | Direct | Aug 7, 2017 (3d) |
| Jul 10, 2017 | XENT | ↓ Sell | 12,835 | $27.18 | $349K | Direct | Jul 12, 2017 (2d) |
| May 20, 2011 | AMRS | ↓ Sell | 3,599 | $28.00 | $101K | By the Hilleman/Albright Family Trust da | May 23, 2011 (3d) |
| May 19, 2011 | AMRS | ↓ Sell | 9,401 | $28.00 | $263K | By the Hilleman/Albright Family Trust da | May 20, 2011 (1d) |
| Apr 15, 2011 | AMRS | ↓ Sell | 19,885 | $26.28 | $523K | Direct | Apr 19, 2011 (4d) |
| Apr 15, 2011 | AMRS | ↓ Sell | 16,115 | $26.28 | $424K | By the Hilleman/Albright Family Trust da | Apr 19, 2011 (4d) |
| May 2, 2006 | SMMX | ↓ Sell10b5-1 | 10,000 | $29.24 | $292K | Family Trust | May 3, 2006 (1d) |
| Feb 16, 2006 | SMMX | ↓ Sell10b5-1 | 10,000 | $26.74 | $267K | Family Trust | Feb 17, 2006 (1d) |
| Nov 2, 2005 | SMMX | ↓ Sell10b5-1 | 5,713 | $26.45 | $151K | Family Trust | Nov 4, 2005 (2d) |
| Nov 1, 2005 | SMMX | ↓ Sell10b5-1 | 4,287 | $26.30 | $113K | Family Trust | Nov 3, 2005 (2d) |
| Aug 11, 2005 | SMMX | ↓ Sell10b5-1 | 1,885 | $28.55 | $54K | Family Trust | Aug 15, 2005 (4d) |
| Aug 10, 2005 | SMMX | ↓ Sell10b5-1 | 3,372 | $28.89 | $97K | Family Trust | Aug 11, 2005 (1d) |
| Aug 3, 2005 | SMMX | ↓ Sell10b5-1 | 2,456 | $29.53 | $73K | Family Trust | Aug 5, 2005 (2d) |
| Aug 2, 2005 | SMMX | ↓ Sell10b5-1 | 2,287 | $29.79 | $68K | Family Trust | Aug 3, 2005 (1d) |
| May 13, 2005 | SMMX | ↓ Sell10b5-1 | 2,957 | $24.82 | $73K | Family Trust | May 16, 2005 (3d) |
| May 10, 2005 | SMMX | ↓ Sell10b5-1 | 3,014 | $26.00 | $78K | Family Trust | May 11, 2005 (1d) |
| May 4, 2005 | SMMX | ↓ Sell10b5-1 | 4,029 | $25.43 | $102K | Family Trust | May 6, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCR insiders
Open-market trades in the last 12 months
About Jeryl L Hilleman's insider trades
Jeryl L Hilleman is an insider at NovoCure (NVCR). Since May 4, 2005, Jeryl has reported 1 open-market purchase worth $5K and 37 sales worth $11.0M on SEC Form 4. In the last 12 months: 1 sale ($46K).
13 sales (17% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (62 filings), option exercises (31 filings), shares withheld for taxes (4 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.